Login
Home / 600196.SS : SHH
Follow Compare
AI Analysis Fundamentals Valuation Video Analysis Similar
Quarterly Quarterly (TTM) Annually

AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

¥21.81 -$5.46 (-20.02%)
SHH · 15 Sep 2026 07:00 UTC
Previous Close
¥21.95
Day Range
¥21.78¥22.06
Year Range
¥20.85¥32.36
Market Cap
57.57B
AVG Volume
26.64M
Trailing/Forward PE
17.04/13.67
PEG ratio
1.43
Dividend Yield
1.79%
Next Earnings Date
2026-11-03
Primary Exchange
Shanghai Stock ExchangeCN
Revenue (CNY)
05B10B15B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Net Income (CNY)
0250M500M750M1B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Operating Income (CNY)
0500M1B1.5B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
EBITDA (CNY)
01B2B3B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Cash Flows (CNY)
-500M0500M1B1.5B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
EPS (CNY)
00.10.20.30.424 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Expenses (CNY)
02B4B6B8BR&DSG&ACapex24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Cash & Debt (CNY)
010B20B30B40BCashLong Term DebtShort Term Debt24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Debt ratios
024624 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Margins
0%20%40%60%24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Return on Capital
0%0.5%1%1.5%2%24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Shares Outstanding
01B2B3B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Dividends (CNY)
00.20.40.6Aug 17Aug 18Aug 19Jul 20Jul 21Jun 22Aug 23Aug 24Aug 25Jul 26
Book Value Per Share (CNY)
010203024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Total Assets (CNY)
050B100B150B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
PE Ratio
10203040med 23.1Dec 24Apr 25Jul 25Oct 25Feb 26Jun 26Sep 26
Free Cash Flow Yield
-2%-1%0%1%2%3%med 0.5%Dec 24Apr 25Jul 25Oct 25Feb 26Jun 26Sep 26
Price to Sales
1.21.41.61.822.2med 1.67Dec 24Apr 25Jul 25Oct 25Feb 26Jun 26Sep 26
EV/EBITDA
10152025med 15.98Dec 24Apr 25Jul 25Oct 25Feb 26Jun 26Sep 26
Price/Operating Cashflow
7.51012.51517.520med 12.85Dec 24Apr 25Jul 25Oct 25Feb 26Jun 26Sep 26
Price to Book
0.811.21.4med 1.13Dec 24Apr 25Jul 25Oct 25Feb 26Jun 26Sep 26
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
600196.SS
Stockpicker

Video analysis: 600196.SS

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.